ACTRN12617000244303
Completed
Phase 1
An experimental study to characterise the in vivo safety and infectivity of a Plasmodium falciparum Cam3.II^R539T (K13) artemisinin-resistant isolate in healthy participants.
ConditionsMalaria infection
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Malaria infection
- Sponsor
- QIMR Berghofer Medical Research Institute
- Enrollment
- 2
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
An experimental study to characterize the in vivo infectivity of the Plasmodium falciparum isolate HMP02Pf in healthy human volunteers.MalariaInfection - Other infectious diseasesACTRN12612000824864The Queensland Institute of Medical Research2
Completed
Phase 1
An experimental study to characterize the in vivo safety and infectivity of the Plasmodium vivax isolate HMPBS-Pv in humans (QP12C14)ACTRN12612001096842The Queensland Institute of Medical Research2
Completed
Phase 1
An Experimental Study To Characterise the in vivo Infectivity in Humans of the in vitro Expanded Blood Stage Plasmodium Falciparum Line QIMR3D7PfMalariaInfection - Studies of infection and infectious agentsACTRN12613000669796Queensland Institute of Medical Research2
Completed
Phase 1
Blood stage pilot challenge study to assess the safety and the infectivity of Plasmodium malariae isolate (HMPBS-Pm) in healthy volunteersMalaria infection with P. malariae strainACTRN12617000048381QIMR Berghofer Medical Research Institute 2
Recruiting
Not Applicable
Development of an ex vivo method for evaluation of the mitochondrial functioMELASJPRN-UMIN000018993Kawasaki Medical School10